Globus Medical

Globus Medical announced the acquisition of Higgs Boson Health, a Durham (North Carolina)-based digital-health startup spun out of Duke University. Higgs Boson brings software developers and AI scientists and will be integrated into Globus Medical’s division for digital health technologies. The technology will become part of the “Surgical Intelligence” pillar and be used across the entire patient journey; financial details were not disclosed. » More on de.investing.com

Globus Medical reported Q2 revenue of $789.6 million and a record non‑GAAP EPS of $1.34; GAAP EPS of $1.10 matched analysts’ estimates. Adjusted EBITDA margin rose to 35.4% and the company generated strong operating cash flow of $412.1 million in the first half of the year. Globus reaffirmed full‑year revenue guidance of $3.18–3.22 billion and raised its non‑GAAP EPS outlook to $4.95–5.05; the stock reacted positively in after‑hours trading. Management cited margin expansion, market‑share gains in spine and trauma, and continued investments in the product pipeline and enabling technologies. » More on de.investing.com

Madison Small Cap Fund liquidated its multi-year position in Globus Medical, saying the company's post-acquisition success and robotics adoption pushed market value above its intrinsic estimate. The fund cited a market cap near $12 billion and an intrinsic value of $85 per share versus a roughly $90 market price, and said it will reallocate to smaller opportunities. Fund performance and broader market context (value outperformance, AI/geopolitical volatility) were noted in the Q1 2026 letter. » More on finance.yahoo.com